NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $201,174 | -34.7% | 1,975 | -45.3% | 0.13% | -27.9% |
| Q1 2021 | $308,000 | -10.2% | 3,609 | -0.7% | 0.18% | -21.8% |
| Q4 2020 | $343,000 | +6.2% | 3,633 | -2.3% | 0.23% | -3.0% |
| Q3 2020 | $323,000 | -0.6% | 3,718 | 0.0% | 0.24% | -1.7% |
| Q2 2020 | $325,000 | +5.9% | 3,718 | 0.0% | 0.24% | -11.4% |
| Q1 2020 | $307,000 | -12.8% | 3,718 | 0.0% | 0.27% | +15.8% |
| Q4 2019 | $352,000 | +9.0% | 3,718 | 0.0% | 0.23% | +2.2% |
| Q3 2019 | $323,000 | -4.7% | 3,718 | 0.0% | 0.23% | -5.0% |
| Q2 2019 | $339,000 | -5.0% | 3,718 | 0.0% | 0.24% | -1.6% |
| Q1 2019 | $357,000 | +11.9% | 3,718 | 0.0% | 0.24% | +0.8% |
| Q4 2018 | $319,000 | -0.3% | 3,718 | 0.0% | 0.24% | +7.5% |
| Q3 2018 | $320,000 | +13.9% | 3,718 | 0.0% | 0.23% | +7.6% |
| Q2 2018 | $281,000 | -6.6% | 3,718 | 0.0% | 0.21% | -10.3% |
| Q1 2018 | $301,000 | -3.5% | 3,718 | 0.0% | 0.23% | +0.9% |
| Q4 2017 | $312,000 | – | 3,718 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |